122 related articles for article (PubMed ID: 17548462)
1. Decrease in intracellular concentration causes the shift in Km value of efflux pump substrates.
Korjamo T; Kemiläinen H; Heikkinen AT; Mönkkönen J
Drug Metab Dispos; 2007 Sep; 35(9):1574-9. PubMed ID: 17548462
[TBL] [Abstract][Full Text] [Related]
2. Effects of experimental setup on the apparent concentration dependency of active efflux transport in in vitro cell permeation experiments.
Heikkinen AT; Korjamo T; Lepikkö V; Mönkkönen J
Mol Pharm; 2010 Apr; 7(2):605-17. PubMed ID: 20163161
[TBL] [Abstract][Full Text] [Related]
3. Design, data analysis, and simulation of in vitro drug transport kinetic experiments using a mechanistic in vitro model.
Poirier A; Lavé T; Portmann R; Brun ME; Senner F; Kansy M; Grimm HP; Funk C
Drug Metab Dispos; 2008 Dec; 36(12):2434-44. PubMed ID: 18809732
[TBL] [Abstract][Full Text] [Related]
4. Kinetic identification of membrane transporters that assist P-glycoprotein-mediated transport of digoxin and loperamide through a confluent monolayer of MDCKII-hMDR1 cells.
Acharya P; O'Connor MP; Polli JW; Ayrton A; Ellens H; Bentz J
Drug Metab Dispos; 2008 Feb; 36(2):452-60. PubMed ID: 17967933
[TBL] [Abstract][Full Text] [Related]
5. Permeability, transport, and metabolism of solutes in Caco-2 cell monolayers: a theoretical study.
Sun H; Pang KS
Drug Metab Dispos; 2008 Jan; 36(1):102-23. PubMed ID: 17932224
[TBL] [Abstract][Full Text] [Related]
6. In situ kinetic modelling of intestinal efflux in rats: functional characterization of segmental differences and correlation with in vitro results.
González-Alvarez I; Fernández-Teruel C; Casabó-Alós VG; Garrigues TM; Polli JE; Ruiz-García A; Bermejo M
Biopharm Drug Dispos; 2007 Jul; 28(5):229-39. PubMed ID: 17410527
[TBL] [Abstract][Full Text] [Related]
7. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).
Usansky HH; Sinko PJ
J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900
[TBL] [Abstract][Full Text] [Related]
8. Scaling of in vitro membrane permeability to predict P-glycoprotein-mediated drug absorption in vivo.
Shirasaka Y; Masaoka Y; Kataoka M; Sakuma S; Yamashita S
Drug Metab Dispos; 2008 May; 36(5):916-22. PubMed ID: 18276834
[TBL] [Abstract][Full Text] [Related]
9. Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport.
Varma MV; Sateesh K; Panchagnula R
Mol Pharm; 2005; 2(1):12-21. PubMed ID: 15804173
[TBL] [Abstract][Full Text] [Related]
10. If the KI is defined by the free energy of binding to P-glycoprotein, which kinetic parameters define the IC50 for the Madin-Darby canine kidney II cell line overexpressing human multidrug resistance 1 confluent cell monolayer?
Lumen AA; Acharya P; Polli JW; Ayrton A; Ellens H; Bentz J
Drug Metab Dispos; 2010 Feb; 38(2):260-9. PubMed ID: 19889884
[TBL] [Abstract][Full Text] [Related]
11. pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs: kinetic analysis of quinidine efflux in situ.
Varma MV; Panchagnula R
J Pharm Sci; 2005 Dec; 94(12):2632-43. PubMed ID: 16258992
[TBL] [Abstract][Full Text] [Related]
12. Effect of P-glycoprotein expression levels on the concentration-dependent permeability of drugs to the cell membrane.
Shirasaka Y; Sakane T; Yamashita S
J Pharm Sci; 2008 Jan; 97(1):553-65. PubMed ID: 17828734
[TBL] [Abstract][Full Text] [Related]
13. Estimation of Michaelis-Menten constant of efflux transporter considering asymmetric permeability.
Sugano K; Shirasaka Y; Yamashita S
Int J Pharm; 2011 Oct; 418(2):161-7. PubMed ID: 21497189
[TBL] [Abstract][Full Text] [Related]
14. P-Glycoprotein (P-gp) expressed in a confluent monolayer of hMDR1-MDCKII cells has more than one efflux pathway with cooperative binding sites.
Acharya P; Tran TT; Polli JW; Ayrton A; Ellens H; Bentz J
Biochemistry; 2006 Dec; 45(51):15505-19. PubMed ID: 17176072
[TBL] [Abstract][Full Text] [Related]
15. Intestinal efflux transport kinetics of green tea catechins in Caco-2 monolayer model.
Chan KY; Zhang L; Zuo Z
J Pharm Pharmacol; 2007 Mar; 59(3):395-400. PubMed ID: 17331343
[TBL] [Abstract][Full Text] [Related]
16. In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system.
Feng B; Mills JB; Davidson RE; Mireles RJ; Janiszewski JS; Troutman MD; de Morais SM
Drug Metab Dispos; 2008 Feb; 36(2):268-75. PubMed ID: 17962372
[TBL] [Abstract][Full Text] [Related]
17. Absorption properties and P-glycoprotein activity of modified Caco-2 cell lines.
Korjamo T; Honkakoski P; Toppinen MR; Niva S; Reinisalo M; Palmgrén JJ; Mönkkönen J
Eur J Pharm Sci; 2005 Nov; 26(3-4):266-79. PubMed ID: 16111871
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms underlying saturable intestinal absorption of metformin.
Proctor WR; Bourdet DL; Thakker DR
Drug Metab Dispos; 2008 Aug; 36(8):1650-8. PubMed ID: 18458049
[TBL] [Abstract][Full Text] [Related]
19. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
[TBL] [Abstract][Full Text] [Related]
20. A structural model for the mass action kinetic analysis of P-gp mediated transport through confluent cell monolayers.
Bentz J; Ellens H
Methods Mol Biol; 2014; 1113():289-316. PubMed ID: 24523118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
